Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00890383Phase 4Completed
Phase 4, randomised, open-label trial of Volulyte in severe trauma and hemorrhagic shock (2 arms), sponsored by University of the Philippines. Primary endpoint: Intraabdominal hypertension at 30 days. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00890383.